An international team of researchers led by renowned stem cell scientist Professor Martin Pera has discovered a novel marker that plays an important role in our understanding of how cancer develops in the liver, pancreas and oesophagus.
The study, published in the journal Stem Cell, adds to our understanding of the role of stem and next stage progenitor cells in tissue regeneration and in the diagnosis and treatment of cancer.
While stem cells are known to reside in organs such as the liver and pancreas, they are difficult to isolate. The new findings show that an antibody developed by the team
Australian scientists have developed a new technique using stem cells, in the hope to replace damaged cells in Parkinson’s disease. The technique could be developed for application in other degenerative conditions.
Drs Clare Parish and Lachlan Thompson lead the research from the Florey Neuroscience Institutes and the University of Melbourne. They are members of the newly established Stem Cells Australia collaboration launched at the University of Melbourne today.
Stem Cells Australia is a new $21m Australian Research Council Special Research Initiative bringing together Australia’s leading stem cell scientists.
Led by internationally renowned stem cell expert Professor Martin Pera and administered by the